Scientific Advosory Board
Hilde Cheroutre, PH.D.
Dr. Cheroutre is on the cutting edge of research. She wants to understand the immune system at a fundamental level and is continuously exploring new and unique ways to examine the organization and function of the immune system and to identify the underlying causes of immune-related diseases, like autoimmunity. Her work is centred around one goal: to discover the truth.
Adam Buntzman, Ph.D.
Dedicated his life to the study of the immune system, with the goal of answering the deepest of questions… How do I recognize “my body” as different from the outside world?
How do we use the knowledge that we have learned about the immune system to develop tools and treatments to keep our loved ones safe from attack by harmful pathogens.
Pere Santamaria, M.D., Ph.D.
Dr. Santamaria’s work has focused on immunogenetics and immunopathogenesis of autoimmune disorders. His work has led to the discovery of a new therapeutic platform based on nanomedicine. This therapeutic approach can suppress the progression of various spontaneous and experimental autoimmune disorders in mice without compromising systemic immunity.
Dean Tantin, PhD
Dr. Tantin is an Associate Professor in the Department of Pathology at the University of Utah and a member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute.
Dr. Tantin studies gene expression and its relationship to immune and stem cell function, and malignancy. He focuses on a class of transcription factors that have been tied to cellular reprogramming and immune function.
Juan Carlos Zúñiga-Pflücker, PhD
Zúñiga-Pflücker obtained his B.Sc.in zoology from the University of Maryland, U.S. in 1987 and his PhD in genetics and immunology from George Washington University in 1991. He is a Senior scientist, Biological Sciences at the Odette Cancer Research Program at the Sunnybrook Research Institute. He is also the former Chair of the Department of Immunology at the University of Toronto. He is a Fellow of Trinity College at the University of Toronto, and a Member of the collaborative graduate program in developmental biology.
Mitchell Kronenberg, Ph.D.
Dr. Kronenberg was La Jolla Institute for Immunology’s President for two decades and still found time to run his own lab. His lab studies how natural killer T cells survive, grow and regulate other immune cell types. Dr. Kronenberg has received several major scientific awards throughout his career, and he is one of the most highly cited immunologists in the world.
Board of Directors
Laurie Venning
Whitney Dueck
Nassar Al - Huraibi
John DaSilva